Romiplostim therapy as a second‐line treatment before splenectomy for refractory immune thrombocytopenia in a cirrhotic patient with iatrogenic Cushing syndrome secondary to corticosteroids | Zendy

Casanovas Taltavull Teresa | Zendy; PeñaCala Maria Carmen | Zendy

Open Access

Romiplostim therapy as a second‐line treatment before splenectomy for refractory immune thrombocytopenia in a cirrhotic patient with iatrogenic Cushing syndrome secondary to corticosteroids

Author(s) -

Casanovas Taltavull Teresa,

PeñaCala Maria Carmen

Publication year - 2017

Publication title -

clinical case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.21

H-Index - 9

ISSN - 2050-0904

DOI - 10.1002/ccr3.667

Subject(s) - medicine , romiplostim , splenectomy , refractory (planetary science) , immune thrombocytopenia , surgery , thrombopoietin , platelet , spleen , genetics , physics , stem cell , haematopoiesis , astrobiology , biology

Key Clinical Message Our case report discusses the usefulness of administering romiplostim as a second‐line treatment before splenectomy in a cirrhotic patient with immune thrombocytopenia who developed corticosteroid‐induced Cushing's syndrome. Corticosteroids were tapered and consequently withdrawn. The patient made a full recovery postsplenectomy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research